Antibody (Suitable for clinical applications)
Specification | Recommendation |
---|---|
Recommended Dilution (Conc) | 1:50-1:100 |
Pretreatment | Citrate Buffer pH 6.0 |
Incubation Parameters | 30 min at Room Temperature |
Prior to use, inspect vial for the presence of any precipitate or other unusual physical properties. These can indicate that the antibody has degraded and is no longer suitable for patient samples. Please run positive and negative controls simultaneously with all patient samples to account and control for errors in laboratory procedure. Use of methods or materials not recommended by enQuire Bio including change to dilution range and detection system should be routinely validated by the user.
Granzyme B Information for Pathologists
Summary:
Enzyme associated with cytotoxic T lymphocytes; induces apoptosis in target cells of these lymphocytes.
Granzyme B General Information | |
---|---|
Alternate Names | |
Molecular Weight | |
27.7 kDa | |
Chromosomal Location | |
q12 [chr: 14] [chr_start: 24630954] [chr_end: 24634267] [strand: -1] | |
Curated Database and Bioinformatic Data | |
Gene Symbol | GZMB |
Entrez Gene ID | 3002 |
RefSeq Protein Accession(s) | NP_004122 |
RefSeq mRNA Accession(s) | NM_001346011; NR_144343; NM_004131; |
RefSeq Genomic Accession(s) | NC_000014; NG_028340 |
UniProt ID(s) | P10144 |
KEGG Gene ID(s) | hsa:3002 |
General Description of Granzyme B . | |
This antibody reacts with a 32 kDa protein. Granzymes are neutral serine proteases, which are stored in specialized lytic granules of cytotoxic T lymphocytes (CTL) and in natural killer (NK) cells. A number of granzymes (A to G) have been isolated and cloned. Human granzyme B is involved in target cell apoptosis during lymphocyte-mediated cytotoxicity. This antibody is useful in the localization of granzyme B containing lytic granules and for the characterization of activated CTL or NK cells. |
There are no reviews yet.